Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for analgesia during retinopathy of prematurity examination in preterm infants
ChiCTR1900024941Phase 4Not yet recruiting
- Sponsor
- Shanghai Children's Medical Center
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and glucose in retinopathy of prematurity (ROP) (2 arms), sponsored by Shanghai Children's Medical Center. Primary endpoint: Neonatal Pain, Agitation and Sedation Scale. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
dexmedetomidineglucose
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on ChiCTR1900024941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024941.